Pharmaceutical manufacturers have not “initiated” nearly two thirds of the studies they’ve pledged to regulators to perform looking at the safety of drugs already on the U.S. market, according to the Food and Drug Administration.
Pharmaceutical manufacturers have not “initiated” nearly two thirds of the studies they’ve pledged to regulators to perform looking at the safety of drugs already on the U.S. market, according to the Food and Drug Administration.
